Divi's Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 11, 2025
DIVISLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Divi's Laboratories has informed the exchanges that its 35th Annual General Meeting (AGM) will be held on Monday, August 11, 2025, at 10:00 a.m. IST via video conferencing. The key business items include adoption of audited standalone and consolidated financial statements for FY25, declaration of a dividend of ₹30 per equity share (face value ₹2, i.e., 1,500%) for FY 2024-25, and re-appointment of Ms. Nilima Prasad Divi and Dr. S. Devendra Rao as directors, who retire by rotation. Special business items include appointment of M/s. V. Bhaskara Rao & Co. as Secretarial Auditors for five years (FY 2025-26 to FY 2029-30), and approval to enhance the monthly remuneration of Mr. Nimmagadda Venkata Anirudh, Head of Nutraceuticals and son of Executive Director Mr. N.V. Ramana, to ₹4,00,000 effective September 1, 2025. The record date for dividend eligibility is July 25, 2025, with payments starting from August 16, 2025. Remote e-voting will be open from August 7 to August 10, 2025.
This is largely a routine AGM notice, but it confirms a strong dividend payout of ₹30 per share — a key positive for income-focused investors; the stock will trade ex-dividend based on the July 25 record date. The related-party remuneration resolution (for the Executive Director's son) is a standard governance item but may attract scrutiny from governance-focused shareholders.